6 Einträge gefunden

1. Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.

   1. Müller, Juliane
   2. Ehlers, Arne
   3. Burkhardt, Lia
   4. Sirma, Hüseyin
   5. Steuber, Thomas
   6. Graefen, Markus
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
2. High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer.

   1. Jacobsen, Frank
   2. Ashtiani, Sharad Nouraie
   3. Tennstedt, Pierre
   4. Heinzer, Hans
   5. Simon, Ronald
   6. Sauter, Guido
   7. Sirma, Hüseyin

   2013 - Forschungsinformationssystem des UKE
3. Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer

   1. Minner, Sarah Jane Pauline
   2. De Silva, Colin
   3. Rink, Michael
   4. Dahlem, Roland
   5. Chun, Felix
   6. Fisch, Margit
   7. Höppner, Wolfgang

   2012 - Forschungsinformationssystem des UKE
4. Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age.

   1. Stahl, Phillip
   2. Kilgué, Adisa
   3. Tennstedt, Pierre
   4. Minner, Sarah Jane Pauline
   5. Krohn, Antje
   6. Simon, Ronald
   7. Krause, Geske

   2012 - Forschungsinformationssystem des UKE
5. ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

   1. Minner, Sarah Jane Pauline
   2. Enodien, Malaika
   3. Sirma, Hüseyin
   4. Lübke, Andreas
   5. Krohn, Antje
   6. Mayer, Pascale S
   7. Simon, Ronald

   2011 - Forschungsinformationssystem des UKE
6. No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.

   1. Stieler, Kristin
   2. Schindler, Sarah
   3. Schlomm, Thorsten
   4. Hohn, Oliver
   5. Bannert, Norbert
   6. Simon, Ronald
   7. Minner, Sarah Jane Pauline

   2011 - Forschungsinformationssystem des UKE - frei zugänglich